{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:30:39Z","timestamp":1794022239855,"version":"4.8.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Carmosino19LAMINOPATIE"},{"name":"Carmosino21RIL"},{"name":"DICLIMAX"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      We previously demonstrated that an Italian family affected by a severe dilated cardiomyopathy (DCM) with history of sudden deaths at young age, carried a mutation in the\n                      <jats:italic>Lmna<\/jats:italic>\n                      gene encoding for a truncated variant of the Lamin A\/C protein (LMNA), R321X. When expressed in heterologous systems, such variant accumulates into the endoplasmic reticulum (ER), inducing the activation of the PERK-CHOP pathway of the unfolded protein response (UPR), ER dysfunction and increased rate of apoptosis. The aim of this work was to analyze whether targeting the UPR can be used to revert the ER dysfunction associated with LMNA R321X expression in HL-1 cardiac cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      HL-1 cardiomyocytes stably expressing LMNA R321X\u00a0were used to assess the ability of 3 different drugs targeting the UPR, salubrinal, guanabenz and empagliflozin to rescue ER stress and dysfunction. In these cells, the state of activation of both the UPR and the pro-apoptotic pathway were analyzed monitoring the expression levels of phospho-PERK, phospho-eIF2\u03b1, ATF4, CHOP and PARP-CL. In addition, we measured ER-dependent intracellular Ca\n                      <jats:sup>2+<\/jats:sup>\n                      dynamics as indicator of proper ER functionality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found that salubrinal and guanabenz increased the expression levels of phospho-eIF2\u03b1 and downregulated the apoptosis markers CHOP and PARP-CL in LMNA\u00a0R321X-cardiomyocytes, maintaining the so-called adaptive UPR. These drugs also restored ER ability to handle Ca\n                      <jats:sup>2+<\/jats:sup>\n                      in these cardiomyocytes. Interestingly, we found that empagliflozin downregulated the apoptosis markers CHOP and PARP-CL shutting down the UPR itself through the inhibition of PERK phosphorylation in LMNA\u00a0R321X-cardiomyocytes. Furthermore, upon empagliflozin treatment, ER homeostasis, in terms of ER ability to store and release intracellular Ca\n                      <jats:sup>2+<\/jats:sup>\n                      was also restored in these cardiomyocytes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We provided evidence that the different drugs, although interfering with different steps of the UPR, were able to counteract pro-apoptotic processes and to preserve the ER homeostasis in R321X LMNA-cardiomyocytes. Of note, two of the tested drugs, guanabenz and empagliflozin, are already used in the clinical practice, thus providing preclinical evidence for ready-to-use therapies in patients affected by the LMNA R321X\u00a0associated cardiomyocytes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-023-04170-y","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T08:02:01Z","timestamp":1684742521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Targeting unfolded protein response reverts ER stress and ER Ca2+ homeostasis in cardiomyocytes expressing the pathogenic variant of Lamin A\/C R321X"],"prefix":"10.1186","volume":"21","author":[{"given":"Giusy","family":"Pietrafesa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"De Zio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Ida","family":"Scorza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Francesca","family":"Armentano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martino","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Forleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Procino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gerbino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Svelto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7600-8816","authenticated-orcid":false,"given":"Monica","family":"Carmosino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,22]]},"reference":[{"issue":"10","key":"4170_CR1","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/boc.201400033","volume":"106","author":"M Carmosino","year":"2014","unstructured":"Carmosino M, Torretta S, Procino G, Gerbino A, Forleo C, Favale S, Svelto M. Role of nuclear Lamin A\/C in cardiomyocyte functions. Biol Cell. 2014;106(10):346\u201358.","journal-title":"Biol Cell"},{"key":"4170_CR2","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3389\/fphys.2018.01356","volume":"9","author":"A Gerbino","year":"2018","unstructured":"Gerbino A, Procino G, Svelto M, Carmosino M. Role of Lamin A\/C gene mutations in the signaling defects leading to cardiomyopathies. Front Physiol. 2018;9:1356.","journal-title":"Front Physiol"},{"issue":"3","key":"4170_CR3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/6799","volume":"21","author":"G Bonne","year":"1999","unstructured":"Bonne G, Di Barletta MR, Varnous S, Becane HM, Hammouda EH, Merlini L, Muntoni F, Greenberg CR, Gary F, Urtizberea JA, et al. Mutations in the gene encoding lamin A\/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet. 1999;21(3):285\u20138.","journal-title":"Nat Genet"},{"issue":"1","key":"4170_CR4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1080\/19491034.2018.1489195","volume":"9","author":"G Peretto","year":"2018","unstructured":"Peretto G, Sala S, Benedetti S, Di Resta C, Gigli L, Ferrari M, Della Bella P. Updated clinical overview on cardiac laminopathies: an electrical and mechanical disease. Nucleus. 2018;9(1):380\u201391.","journal-title":"Nucleus"},{"issue":"1","key":"4170_CR5","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1038\/s41467-019-09929-w","volume":"10","author":"N Salvarani","year":"2019","unstructured":"Salvarani N, Crasto S, Miragoli M, Bertero A, Paulis M, Kunderfranco P, Serio S, Forni A, Lucarelli C, Dal Ferro M, et al. The K219T-Lamin mutation induces conduction defects through epigenetic inhibition of SCN5A in human cardiac laminopathy. Nat Commun. 2019;10(1):2267.","journal-title":"Nat Commun"},{"issue":"5","key":"4170_CR6","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.stem.2020.12.016","volume":"28","author":"PP Shah","year":"2021","unstructured":"Shah PP, Lv W, Rhoades JH, Poleshko A, Abbey D, Caporizzo MA, Linares-Saldana R, Heffler JG, Sayed N, Thomas D, et al. Pathogenic LMNA variants disrupt cardiac lamina\u2013chromatin interactions and de-repress alternative fate genes. Cell Stem Cell. 2021;28(5):938-954e939.","journal-title":"Cell Stem Cell"},{"issue":"24","key":"4170_CR7","first-page":"4043","volume":"28","author":"C Macquart","year":"2019","unstructured":"Macquart C, Juttner R, Morales Rodriguez B, Le Dour C, Lefebvre F, Chatzifrangkeskou M, Schmitt A, Gotthardt M, Bonne G, Muchir A. Microtubule cytoskeleton regulates Connexin 43 localization and cardiac conduction in cardiomyopathy caused by mutation in A-type lamins gene. Hum Mol Genet. 2019;28(24):4043\u201352.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"4170_CR8","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1172\/JCI29042","volume":"117","author":"A Muchir","year":"2007","unstructured":"Muchir A, Pavlidis P, Decostre V, Herron AJ, Arimura T, Bonne G, Worman HJ. Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. J Clin Invest. 2007;117(5):1282\u201393.","journal-title":"J Clin Invest"},{"issue":"2","key":"4170_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/cvr\/cvr301","volume":"93","author":"A Muchir","year":"2012","unstructured":"Muchir A, Reilly SA, Wu W, Iwata S, Homma S, Bonne G, Worman HJ. Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A\/C gene. Cardiovasc Res. 2012;93(2):311\u20139.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"4170_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2044-5040-3-17","volume":"3","author":"A Muchir","year":"2013","unstructured":"Muchir A, Kim YJ, Reilly SA, Wu W, Choi JC, Worman HJ. Inhibition of extracellular signal-regulated kinase 1\/2 signaling has beneficial effects on skeletal muscle in a mouse model of Emery-Dreifuss muscular dystrophy caused by lamin A\/C gene mutation. Skelet Muscle. 2013;3(1):17.","journal-title":"Skelet Muscle"},{"issue":"2","key":"4170_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/hmg\/ddn343","volume":"18","author":"A Muchir","year":"2009","unstructured":"Muchir A, Shan J, Bonne G, Lehnart SE, Worman HJ. Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins. Hum Mol Genet. 2009;18(2):241\u20137.","journal-title":"Hum Mol Genet"},{"issue":"23","key":"4170_CR12","doi-asserted-by":"publisher","first-page":"10902","DOI":"10.1111\/jcmm.16975","volume":"25","author":"A Gerbino","year":"2021","unstructured":"Gerbino A, Forleo C, Milano S, Piccapane F, Procino G, Pepe M, Piccolo M, Guida P, Resta N, Favale S, et al. Pro-inflammatory cytokines as emerging molecular determinants in cardiolaminopathies. J Cell Mol Med. 2021;25(23):10902\u201315.","journal-title":"J Cell Mol Med"},{"key":"4170_CR13","doi-asserted-by":"publisher","first-page":"918760","DOI":"10.3389\/fcell.2022.918760","volume":"10","author":"R De Zio","year":"2022","unstructured":"De Zio R, Pietrafesa G, Milano S, Procino G, Bramerio M, Pepe M, Forleo C, Favale S, Svelto M, Gerbino A, et al. Role of nuclear Lamin A\/C in the regulation of Nav1.5 channel and microtubules: lesson from the pathogenic lamin A\/C variant Q517X. Front Cell Dev Biol. 2022;10:918760.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"4170_CR14","doi-asserted-by":"publisher","first-page":"e001603","DOI":"10.1161\/CIRCGENETICS.116.001603","volume":"10","author":"S Nishiuchi","year":"2017","unstructured":"Nishiuchi S, Makiyama T, Aiba T, Nakajima K, Hirose S, Kohjitani H, Yamamoto Y, Harita T, Hayano M, Wuriyanghai Y, et al. Gene-based risk stratification for cardiac disorders in LMNA mutation carriers. Circ Cardiovasc Genet. 2017;10(6):e001603.","journal-title":"Circ Cardiovasc Genet"},{"issue":"5","key":"4170_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","volume":"59","author":"IA van Rijsingen","year":"2012","unstructured":"van Rijsingen IA, Arbustini E, Elliott PM, Mogensen J, Hermans-van Ast JF, van der Kooi AJ, van Tintelen JP, van den Berg MP, Pilotto A, Pasotti M, et al. Risk factors for malignant ventricular arrhythmias in lamin a\/c mutation carriers a European cohort study. J Am Coll Cardiol. 2012;59(5):493\u2013500.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"4170_CR16","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S0735-1097(02)01724-2","volume":"39","author":"E Arbustini","year":"2002","unstructured":"Arbustini E, Pilotto A, Repetto A, Grasso M, Negri A, Diegoli M, Campana C, Scelsi L, Baldini E, Gavazzi A, et al. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A\/C defect-related disease. J Am Coll Cardiol. 2002;39(6):981\u201390.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"4170_CR17","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1111\/jcmm.12926","volume":"20","author":"M Carmosino","year":"2016","unstructured":"Carmosino M, Gerbino A, Schena G, Procino G, Miglionico R, Forleo C, Favale S, Svelto M. The expression of Lamin A mutant R321X leads to endoplasmic reticulum stress with aberrant Ca(2+) handling. J Cell Mol Med. 2016;20(11):2194\u2013207.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"4170_CR18","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1159\/000485651","volume":"44","author":"A Gerbino","year":"2017","unstructured":"Gerbino A, Bottillo I, Milano S, Lipari M, Zio R, Morlino S, Mola MG, Procino G, Re F, Zachara E, et al. Functional characterization of a novel truncating mutation in Lamin A\/C gene in a family with a severe cardiomyopathy with conduction defects. Cell Physiol Biochem. 2017;44(4):1559\u201377.","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"4170_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrm3270","volume":"13","author":"C Hetz","year":"2012","unstructured":"Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. 2012;13(2):89\u2013102.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1\u20132","key":"4170_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1\u20132):55\u201363.","journal-title":"J Immunol Methods"},{"issue":"2","key":"4170_CR21","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3390\/ijms24021647","volume":"24","author":"SI Scorza","year":"2023","unstructured":"Scorza SI, Milano S, Saponara I, Certini M, De Zio R, Mola MG, Procino G, Carmosino M, Moccia F, Svelto M, et al. TRPML1-induced lysosomal Ca(2+) signals activate AQP2 translocation and water flux in renal collecting duct cells. Int J Mol Sci. 2023;24(2):1647.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4170_CR22","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.celrep.2013.03.024","volume":"3","author":"MD Shoulders","year":"2013","unstructured":"Shoulders MD, Ryno LM, Genereux JC, Moresco JJ, Tu PG, Wu C, Yates JR 3rd, Su AI, Kelly JW, Wiseman RL. Stress-independent activation of XBP1s and\/or ATF6 reveals three functionally diverse ER proteostasis environments. Cell Rep. 2013;3(4):1279\u201392.","journal-title":"Cell Rep"},{"issue":"5","key":"4170_CR23","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1083\/jcb.153.5.1011","volume":"153","author":"I Novoa","year":"2001","unstructured":"Novoa I, Zeng H, Harding HP, Ron D. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J Cell Biol. 2001;153(5):1011\u201322.","journal-title":"J Cell Biol"},{"issue":"3","key":"4170_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017894","volume":"6","author":"HW Yung","year":"2011","unstructured":"Yung HW, Charnock-Jones DS, Burton GJ. Regulation of AKT phosphorylation at Ser473 and Thr308 by endoplasmic reticulum stress modulates substrate specificity in a severity dependent manner. PLoS ONE. 2011;6(3): e17894.","journal-title":"PLoS ONE"},{"issue":"2","key":"4170_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4161\/auto.6.2.11062","volume":"6","author":"L Qin","year":"2010","unstructured":"Qin L, Wang Z, Tao L, Wang Y. ER stress negatively regulates AKT\/TSC\/mTOR pathway to enhance autophagy. Autophagy. 2010;6(2):239\u201347.","journal-title":"Autophagy"},{"issue":"16","key":"4170_CR26","doi-asserted-by":"publisher","first-page":"7193","DOI":"10.1021\/jm300713s","volume":"55","author":"JM Axten","year":"2012","unstructured":"Axten JM, Medina JR, Feng Y, Shu A, Romeril SP, Grant SW, Li WH, Heerding DA, Minthorn E, Mencken T, et al. Discovery of 7-methyl-5-(1-[3-(trifluoromethyl)phenyl]acetyl-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). J Med Chem. 2012;55(16):7193\u2013207.","journal-title":"J Med Chem"},{"issue":"6","key":"4170_CR27","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/cdd.2017.58","volume":"24","author":"D Rojas-Rivera","year":"2017","unstructured":"Rojas-Rivera D, Delvaeye T, Roelandt R, Nerinckx W, Augustyns K, Vandenabeele P, Bertrand MJM. When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157. Cell Death Differ. 2017;24(6):1100\u201310.","journal-title":"Cell Death Differ"},{"key":"4170_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110002","volume":"362","author":"TK Motawi","year":"2022","unstructured":"Motawi TK, Al-Kady RH, Abdelraouf SM, Senousy MA. Empagliflozin alleviates endoplasmic reticulum stress and augments autophagy in rotenone-induced Parkinson\u2019s disease in rats: targeting the GRP78\/PERK\/eIF2alpha\/CHOP pathway and miR-211-5p. Chem Biol Interact. 2022;362: 110002.","journal-title":"Chem Biol Interact"},{"issue":"21","key":"4170_CR29","doi-asserted-by":"publisher","first-page":"12331","DOI":"10.1111\/jcmm.15699","volume":"24","author":"R Madonna","year":"2020","unstructured":"Madonna R, Doria V, Minnucci I, Pucci A, Pierdomenico DS, De Caterina R. Empagliflozin reduces the senescence of cardiac stromal cells and improves cardiac function in a murine model of diabetes. J Cell Mol Med. 2020;24(21):12331\u201340.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"4170_CR30","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.3390\/ijms20102386","volume":"20","author":"S Hamilton","year":"2019","unstructured":"Hamilton S, Terentyev D. Altered intracellular calcium homeostasis and arrhythmogenesis in the aged heart. Int J Mol Sci. 2019;20(10):2386.","journal-title":"Int J Mol Sci"},{"issue":"22","key":"4170_CR31","doi-asserted-by":"publisher","first-page":"13367","DOI":"10.1074\/jbc.273.22.13367","volume":"273","author":"CB Klee","year":"1998","unstructured":"Klee CB, Ren H, Wang X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem. 1998;273(22):13367\u201370.","journal-title":"J Biol Chem"},{"issue":"8","key":"4170_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011925","volume":"5","author":"M Bollo","year":"2010","unstructured":"Bollo M, Paredes RM, Holstein D, Zheleznova N, Camacho P, Lechleiter JD. Calcineurin interacts with PERK and dephosphorylates calnexin to relieve ER stress in mammals and frogs. PLoS ONE. 2010;5(8): e11925.","journal-title":"PLoS ONE"},{"issue":"12","key":"4170_CR33","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1016\/j.cellsig.2014.08.015","volume":"26","author":"Z Liu","year":"2014","unstructured":"Liu Z, Cai H, Zhu H, Toque H, Zhao N, Qiu C, Guan G, Dang Y, Wang J. Protein kinase RNA-like endoplasmic reticulum kinase (PERK)\/calcineurin signaling is a novel pathway regulating intracellular calcium accumulation which might be involved in ventricular arrhythmias in diabetic cardiomyopathy. Cell Signal. 2014;26(12):2591\u2013600.","journal-title":"Cell Signal"},{"issue":"1","key":"4170_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.yjmcc.2011.10.018","volume":"52","author":"J Heineke","year":"2012","unstructured":"Heineke J, Ritter O. Cardiomyocyte calcineurin signaling in subcellular domains: from the sarcolemma to the nucleus and beyond. J Mol Cell Cardiol. 2012;52(1):62\u201373.","journal-title":"J Mol Cell Cardiol"},{"key":"4170_CR35","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.2147\/JIR.S304520","volume":"14","author":"J Zhu","year":"2021","unstructured":"Zhu J, Zhang X, Xie H, Wang Y, Zhang X, Lin Z. Cardiomyocyte Stim1 deficiency exacerbates doxorubicin cardiotoxicity by magnification of endoplasmic reticulum stress. J Inflamm Res. 2021;14:3945\u201358.","journal-title":"J Inflamm Res"},{"issue":"11","key":"4170_CR36","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.2337\/db17-1351","volume":"67","author":"T Kono","year":"2018","unstructured":"Kono T, Tong X, Taleb S, Bone RN, Iida H, Lee CC, Sohn P, Gilon P, Roe MW, Evans-Molina C. Impaired store-operated calcium entry and STIM1 loss lead to reduced insulin secretion and increased endoplasmic reticulum stress in the diabetic beta-cell. Diabetes. 2018;67(11):2293\u2013304.","journal-title":"Diabetes"},{"issue":"12","key":"4170_CR37","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.celrep.2015.05.043","volume":"11","author":"MS Choy","year":"2015","unstructured":"Choy MS, Yusoff P, Lee IC, Newton JC, Goh CW, Page R, Shenolikar S, Peti W. Structural and functional analysis of the GADD34:PP1 eIF2alpha phosphatase. Cell Rep. 2015;11(12):1885\u201391.","journal-title":"Cell Rep"},{"issue":"2","key":"4170_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10238-014-0287-4","volume":"15","author":"W Wang","year":"2015","unstructured":"Wang W, Cheng J, Sun A, Lv S, Liu H, Liu X, Guan G, Liu G. TRB3 mediates renal tubular cell apoptosis associated with proteinuria. Clin Exp Med. 2015;15(2):167\u201377.","journal-title":"Clin Exp Med"},{"issue":"5625","key":"4170_CR39","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1126\/science.1079817","volume":"300","author":"K Du","year":"2003","unstructured":"Du K, Herzig S, Kulkarni RN, Montminy M. TRB3: a tribbles homolog that inhibits Akt\/PKB activation by insulin in liver. Science. 2003;300(5625):1574\u20137.","journal-title":"Science"},{"issue":"5711","key":"4170_CR40","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1126\/science.1101902","volume":"307","author":"M Boyce","year":"2005","unstructured":"Boyce M, Bryant KF, Jousse C, Long K, Harding HP, Scheuner D, Kaufman RJ, Ma D, Coen DM, Ron D, et al. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science. 2005;307(5711):935\u20139.","journal-title":"Science"},{"issue":"5","key":"4170_CR41","doi-asserted-by":"publisher","first-page":"1007e1009","DOI":"10.1016\/j.neurobiolaging.2011.10.007","volume":"33","author":"X Huang","year":"2012","unstructured":"Huang X, Chen Y, Zhang H, Ma Q, Zhang YW, Xu H. Salubrinal attenuates beta-amyloid-induced neuronal death and microglial activation by inhibition of the NF-kappaB pathway. Neurobiol Aging. 2012;33(5):1007e1009-1017.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"4170_CR42","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nn.2297","volume":"12","author":"S Saxena","year":"2009","unstructured":"Saxena S, Cabuy E, Caroni P. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci. 2009;12(5):627\u201336.","journal-title":"Nat Neurosci"},{"issue":"1","key":"4170_CR43","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12017-015-8340-3","volume":"17","author":"V Rubovitch","year":"2015","unstructured":"Rubovitch V, Barak S, Rachmany L, Goldstein RB, Zilberstein Y, Pick CG. The neuroprotective effect of salubrinal in a mouse model of traumatic brain injury. Neuromolecular Med. 2015;17(1):58\u201370.","journal-title":"Neuromolecular Med"},{"issue":"1","key":"4170_CR44","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3892\/mmr.2015.3508","volume":"12","author":"RJ Li","year":"2015","unstructured":"Li RJ, He KL, Li X, Wang LL, Liu CL, He YY. Salubrinal protects cardiomyocytes against apoptosis in a rat myocardial infarction model via suppressing the dephosphorylation of eukaryotic translation initiation factor 2alpha. Mol Med Rep. 2015;12(1):1043\u20139.","journal-title":"Mol Med Rep"},{"issue":"3","key":"4170_CR45","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2165\/00003495-198326030-00003","volume":"26","author":"B Holmes","year":"1983","unstructured":"Holmes B, Brogden RN, Heel RC, Speight TM, Avery GS. Guanabenz. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension. Drugs. 1983;26(3):212\u201329.","journal-title":"Drugs"},{"issue":"6025","key":"4170_CR46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.1201396","volume":"332","author":"P Tsaytler","year":"2011","unstructured":"Tsaytler P, Harding HP, Ron D, Bertolotti A. Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science. 2011;332(6025):91\u20134.","journal-title":"Science"},{"issue":"2","key":"4170_CR47","doi-asserted-by":"publisher","first-page":"R287","DOI":"10.1152\/ajpregu.00123.2002","volume":"283","author":"M Philipp","year":"2002","unstructured":"Philipp M, Brede M, Hein L. Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough. Am J Physiol Regul Integr Comp Physiol. 2002;283(2):R287-295.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"4170_CR48","doi-asserted-by":"publisher","first-page":"H823","DOI":"10.1152\/ajpheart.00986.2003","volume":"286","author":"SM White","year":"2004","unstructured":"White SM, Constantin PE, Claycomb WC. Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. Am J Physiol Heart Circ Physiol. 2004;286(3):H823-829.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4170_CR49","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.nbd.2014.08.010","volume":"71","author":"L Wang","year":"2014","unstructured":"Wang L, Popko B, Tixier E, Roos RP. Guanabenz, which enhances the unfolded protein response, ameliorates mutant SOD1-induced amyotrophic lateral sclerosis. Neurobiol Dis. 2014;71:317\u201324.","journal-title":"Neurobiol Dis"},{"key":"4170_CR50","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neuroscience.2014.03.047","volume":"277","author":"HQ Jiang","year":"2014","unstructured":"Jiang HQ, Ren M, Jiang HZ, Wang J, Zhang J, Yin X, Wang SY, Qi Y, Wang XD, Feng HL. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neuroscience. 2014;277:132\u20138.","journal-title":"Neuroscience"},{"issue":"6231","key":"4170_CR51","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1126\/science.aaa4484","volume":"348","author":"I Das","year":"2015","unstructured":"Das I, Krzyzosiak A, Schneider K, Wrabetz L, D\u2019Antonio M, Barry N, Sigurdardottir A, Bertolotti A. Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit. Science. 2015;348(6231):239\u201342.","journal-title":"Science"},{"issue":"8","key":"4170_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015434","volume":"7","author":"ED Bella","year":"2017","unstructured":"Bella ED, Tramacere I, Antonini G, Borghero G, Capasso M, Caponnetto C, Chio A, Corbo M, Eleopra R, Filosto M, et al. Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial). BMJ Open. 2017;7(8): e015434.","journal-title":"BMJ Open"},{"issue":"6","key":"4170_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098893","volume":"9","author":"C Neuber","year":"2014","unstructured":"Neuber C, Uebeler J, Schulze T, Sotoud H, El-Armouche A, Eschenhagen T. Guanabenz interferes with ER stress and exerts protective effects in cardiac myocytes. PLoS ONE. 2014;9(6): e98893.","journal-title":"PLoS ONE"},{"issue":"22","key":"4170_CR54","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117\u201328.","journal-title":"N Engl J Med"},{"issue":"15","key":"4170_CR55","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med. 2020;383(15):1413\u201324.","journal-title":"N Engl J Med"},{"issue":"4","key":"4170_CR56","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa1812389","volume":"380","author":"SD Wiviott","year":"2019","unstructured":"Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Zelniker TA, Kuder JF, Murphy SA, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2019;380(4):347\u201357.","journal-title":"N Engl J Med"},{"issue":"21","key":"4170_CR57","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Belohlavek J, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381(21):1995\u20132008.","journal-title":"N Engl J Med"},{"key":"4170_CR58","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.yjmcc.2022.03.005","volume":"167","author":"JRB Dyck","year":"2022","unstructured":"Dyck JRB, Sossalla S, Hamdani N, Coronel R, Weber NC, Light PE, Zuurbier CJ. Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: evidence for potential off-target effects. J Mol Cell Cardiol. 2022;167:17\u201331.","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"4170_CR59","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.121.057812","volume":"145","author":"J Butler","year":"2022","unstructured":"Butler J, Filippatos G, Jamal Siddiqi T, Brueckmann M, Bohm M, Chopra VK, Pedro Ferreira J, Januzzi JL, Kaul S, Pina IL, et al. Empagliflozin, health status, and quality of life in patients with heart failure and preserved ejection fraction: the EMPEROR-preserved trial. Circulation. 2022;145(3):184\u201393.","journal-title":"Circulation"},{"issue":"6","key":"4170_CR60","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","volume":"77","author":"C Writing","year":"2021","unstructured":"Writing C, Maddox TM, Januzzi JL Jr, Allen LA, Breathett K, Butler J, Davis LL, Fonarow GC, Ibrahim NE, Lindenfeld J, et al. 2021 Update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021;77(6):772\u2013810.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"4170_CR61","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/ejhf.1954","volume":"22","author":"PM Seferovic","year":"2020","unstructured":"Seferovic PM, Fragasso G, Petrie M, Mullens W, Ferrari R, Thum T, Bauersachs J, Anker SD, Ray R, Cavusoglu Y, et al. Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020;22(9):1495\u2013503.","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"4170_CR62","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1080\/1061186X.2022.2064479","volume":"30","author":"CC Wang","year":"2022","unstructured":"Wang CC, Li Y, Qian XQ, Zhao H, Wang D, Zuo GX, Wang K. Empagliflozin alleviates myocardial I\/R injury and cardiomyocyte apoptosis via inhibiting ER stress-induced autophagy and the PERK\/ATF4\/Beclin1 pathway. J Drug Target. 2022;30(8):858\u201372.","journal-title":"J Drug Target"},{"issue":"2","key":"4170_CR63","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00204-020-02951-8","volume":"95","author":"WT Chang","year":"2021","unstructured":"Chang WT, Lin YW, Ho CH, Chen ZC, Liu PY, Shih JY. Dapagliflozin suppresses ER stress and protects doxorubicin-induced cardiotoxicity in breast cancer patients. Arch Toxicol. 2021;95(2):659\u201371.","journal-title":"Arch Toxicol"},{"issue":"15","key":"4170_CR64","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.119.044183","volume":"141","author":"TA Zelniker","year":"2020","unstructured":"Zelniker TA, Bonaca MP, Furtado RHM, Mosenzon O, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, et al. Effect of dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus: insights from the DECLARE-TIMI 58 trial. Circulation. 2020;141(15):1227\u201334.","journal-title":"Circulation"},{"issue":"1","key":"4170_CR65","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12933-021-01293-8","volume":"20","author":"HL Li","year":"2021","unstructured":"Li HL, Lip GYH, Feng Q, Fei Y, Tse YK, Wu MZ, Ren QW, Tse HF, Cheung BY, Yiu KH. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis. Cardiovasc Diabetol. 2021;20(1):100.","journal-title":"Cardiovasc Diabetol"},{"key":"4170_CR66","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fphys.2018.00257","volume":"9","author":"J Avila-Medina","year":"2018","unstructured":"Avila-Medina J, Mayoral-Gonzalez I, Dominguez-Rodriguez A, Gallardo-Castillo I, Ribas J, Ordonez A, Rosado JA, Smani T. The complex role of store operated calcium entry pathways and related proteins in the function of cardiac, skeletal and vascular smooth muscle cells. Front Physiol. 2018;9:257.","journal-title":"Front Physiol"},{"issue":"9","key":"4170_CR67","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.3390\/ijms17091558","volume":"17","author":"E Bahar","year":"2016","unstructured":"Bahar E, Kim H, Yoon H. ER stress-mediated signaling: action potential and Ca(2+) as key players. Int J Mol Sci. 2016;17(9):1558.","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04170-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04170-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04170-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T08:04:29Z","timestamp":1684742669000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04170-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,22]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4170"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04170-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2583422\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,22]]},"assertion":[{"value":"13 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"340"}}